Gore REVISE Clinical Study Demonstrates Superiority of GORE VIABAHN Endoprosthesis

GORE Device Outperforms Standard Treatment Option for Stenoses or Thrombotic Occlusions

First Patient Enrolled in Gore TAG Thoracic Branch Endoprosthesis LSA Feasibility Study

Multi-Center Study to Assess Feasibility of Gore Device to Treat Historically Challenging Patient Population

Gore Receives FDA Approval for Endovascular Treatment of In-Stent Restenosis with the GORE® VIABAHN® Endoprosthesis

Innovative treatment offers long-term solution for ISR

Gore Receives FDA Approval for 25 cm GORE® VIABAHN® Endoprosthesis

Longest stent-graft introduced in the United States

First Patient Enrolled in Gore TAG Thoracic Branch Endoprosthesis LSA Feasibility Study

Multi-Center Study to Assess Feasibility of Gore Device to Treat Historically Challenging Patient Population

GORE® VIABAHN® Endoprosthesis Found to Provide Superior Patency and Reduced Interventions Versus Balloon Angioplasty Alone for Challenging AV Access Cases

New data from Gore REVISE Clinical Study published online in Journal of Vascular Surgery illustrates role device can play in maintaining and salvaging failing dialysis circuits

First Patients Enrolled in the Gore RELINE MAX Clinical Study

108 patient trial to add evidence for treatment of in-stent restenosis using the GORE® VIABAHN® Endoprosthesis

Unique Biomaterial for Hernia Repair Receives FDA 510K Clearance

GORE® SYNECOR Biomaterial combines strength of PTFE with the tissue-building scaffold of GORE® BIO-A® Web to create an improved device for hernia repair

GORE® EXCLUDER® Iliac Branch Endoprosthesis is First Dedicated System of Its Kind Registered in Australia and New Zealand

First Successful Implants Providing Endovascular Repair to Iliac Arteries Completed in Australia

GORE® EXCLUDER® Iliac Branch Endoprosthesis Gains FDA Approval

Gore designed all-in-one system to preserve iliac artery blood flow in patients with iliac or aortoiliac aneurysms